João Monteiro

Founding Principal @ Pinto Ventures AG | FinTech, LogTech and Future of Retail | Supervisory Board member with digital, restructuring & strategic track record

📍 Walchwil, Zug, Switzerland🔄 Updated September 2026💼 7 investments📅 11 years investing🗓 Last invested Feb 2020
VC🌍 Switzerland
7
Total investments
6
Early stage
1
Mid stage
0
Late stage
11y
Years active

Portfolio

7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor and Board member
Feb 2020
VONZU is a SaaS solution for logistics and delivery, which allows orchestration of the entire supply chain, integrating retailers and logistics operators in the same cloud ecosystem. VONZU technology digitizes and automates every step of the dispatch and delivery process, from origin to destination, and connects all parts of the chain –retailer, logistics operator, delivery person and recipient–, for a more efficient, sustainable distribution of goods. and profitable. With the implementation of VONZU, companies increase their technological and operational capacity, to respond to the exponential growth of last-mile deliveries and to new market demands. Our SaaS solution for logistics and delivery is 100% integrable in multiple sectors. We design the technology of the future for a more integrated, efficient and sustainable distribution.
Investor
Dec 2019
Swiss Tax made so simple, it can be done and submitted in 10 minutes! Powered by A.I.
Investor
Nov 2019
Eisbach Bio is an innovative start-up in biotechnology founded in 2019 as a spin-out of the Biomedical Center Munich. We are developing novel drugs that successfully target molecular vulnerabilities arising in cancer genomes. Eisbach will beat cancer at its own game.
Investor
Jan 2017
Repositive is committed to accelerating the development of precision cancer therapies to the clinic by working with biopharmas and Contract Research Organisations (CROs) to improve the predictivity of pre-clinical cancer research. Through its Cancer Models Scout service, Repositive is helping biopharmas to optimise their pre-clinical cancer projects by identifying the most suitable cancer models for their requirements from its world-leading database of over 8000 models, as well as via outreach to an extended network of CRO contacts. Repositive works to connect researchers with the right CRO partners who have first-class expertise and years of experience in running similar studies, to ensure biopharmas receive the best advice for planning and conducting their oncology projects. Download our latest eBook on AI in drug discovery here: https://mailchi.mp/repositive.io/c1tpoe6oke
Investor
Jul 2016
We’re reimagining the way banking works. We make it easy to manage your money – wherever you are in the world. We create financial freedom for all of us who live, work, travel, study or send money abroad. We’re the mobile app alternative to the banks, offering accounts you can open instantly so that you don’t lose access to the money you need every time you cross a border on a map. We’re here for everyone, not just for those with perfect credit scores or the right set of utility bills. We push the boundaries daily with over 2 million sign-ups across 31 countries.
early stageBanking
Investor
Feb 2016
Medlanes brings medicine online, building the first contact point to healthcare on the internet. 
We offer mobile and online consultations by combining the convenience of the Internet with the quality and reliability of a doctor's visit. 
 The company was founded with the intention of improving the quality of healthcare by providing patients with fast, reliable and affordable advice anywhere in the world. Check out our company website for more information: http://medlanes.com Follow us on: Facebook: http://on.fb.me/1qkke4U Twitter: http://lnkd.in/dpHs9tF
Investor and Board member
Jun 2015
In 2013 a group of real estate and fintech experts based in Tallinn, Estonia had a bright idea. What if they could break down the barriers which ensured that investing in secured property loans was a luxury only available to the wealthy and well-connected? And what if they could help entrepreneurs and visionaries in the property development business who struggle with the ‘one-size-fits all’ solutions offered by banks and major financial institutions at the same time? Thus Estateguru was born. Today, more than half a decade later, we have facilitated more than 3100 loans worth in excess of €500 million. Over 100 000 investors, from all walks of life and hailing from 109 countries, have earned average returns of 11.24% by backing property loans in Estonia, Latvia, Lithuania, Spain, Germany, Sweden and Finland with more markets to follow soon. Due to the large and diversified investor base, with millions of EUR available to lend, our borrowers can get the money they need to realise their plans quickly, on their own terms, and investors can access pre-vetted and diversified, cross-border investment opportunities with a low barrier to entry and total transparency. Join us on our journey of building the bridges in property finance world.
Experience · 14 entries
All (14)
Investments (7)
Founder (2)
Board (2)
2020
Investor and Board member
Feb 2020
VONZU is a SaaS solution for logistics and delivery, which allows orchestration of the entire supply chain, integrating retailers and logistics operators in the same cloud ecosystem. VONZU technology digitizes and automates every step of the dispatch and delivery process, from origin to destination, and connects all parts of the chain –retailer, logistics operator, delivery person and recipient–, for a more efficient, sustainable distribution of goods. and profitable. With the implementation of VONZU, companies increase their technological and operational capacity, to respond to the exponential growth of last-mile deliveries and to new market demands. Our SaaS solution for logistics and delivery is 100% integrable in multiple sectors. We design the technology of the future for a more integrated, efficient and sustainable distribution.
2019
Investor
Dec 2019
Swiss Tax made so simple, it can be done and submitted in 10 minutes! Powered by A.I.
Investor
Nov 2019
Eisbach Bio is an innovative start-up in biotechnology founded in 2019 as a spin-out of the Biomedical Center Munich. We are developing novel drugs that successfully target molecular vulnerabilities arising in cancer genomes. Eisbach will beat cancer at its own game.
Founding Principal
Apr 2019
Pinto Ventures AG is a Seed Capital and Company-Building private fund. Pinto Ventures AG provides Angel investment and support to Seed and pre-Seed startups focusing on FinTech, LogTech and HealthTech. We do scouting and deal advisor-ship for VCs and Corporates on the verticals and the ecosystems we know best.
OttoQuant
Co-Founder
Apr 2019
Show all 14 entries ↓
Investment activity
2015–2020 · 7 investments
2015120162201712019220201
Recent (last 2 years)Earlier